Project Updates and Milestones news (page 43)

23 February 2026

Sasol Advances Strategic Goals, Meets CMD Targets

Sasol reports stable turnover, improved production, and reduced costs. Despite lower earnings, free cash flow rose, supported by strategic initiatives and disciplined management.
23 February 2026

Novo Nordisk: CagriSema Shows 23% Weight Loss in Trial, Misses Primary Endpoint

CagriSema achieved 23% weight loss in 84 weeks but didn't match tirzepatide. Further trials will explore higher doses. Safe profile with mild gastrointestinal effects.
23 February 2026

Sasol Advances Strategic Goals, Meets CMD Targets

Despite a challenging macro environment, Sasol improved production, managed costs, and increased free cash flow, while advancing its Grow and Transform strategy.
21 February 2026

Johnson & Johnson's TREMFYA® Shows Sustained Remission in Ulcerative Colitis Over 3 Years

TREMFYA® maintains clinical, endoscopic, and histologic outcomes in ulcerative colitis through 140 weeks, with high patient retention and no new safety concerns.
20 February 2026

Chugai Launches Japan's First Regenerative Treatment for Duchenne Muscular Dystrophy

ELEVIDYS, a one-time therapy for DMD, targets ambulatory patients aged 3-7. Safety measures and post-marketing studies are in place following reports of liver failure cases.
20 February 2026

Eni Launches Ndungu Full-Field Offshore Angola

Ndungu full-field starts production offshore Angola, boosting output to 60,000 barrels/day. Part of Agogo IWH, it enhances Angola's oil capacity and aligns with low-carbon goals.

The right choices in the European chemical industry

Save time with chemXplore Alpha

Learn more

← Previous Next →